Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab Monotherapy in RA
NCT02087696Phase 4Unknown
- Sponsor
- Fundación Española de Reumatología
- Start
- May 2014
- Primary completion
- Dec 2015
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 4 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Fundación Española de Reumatología. Status: unknown.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02087696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02087696.